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Abstract
Background: Inappropriate medication prescription is a common cause of preventable adverse drug events among elderly
persons in the primary care setting.
Objective: The aim of this systematic review is to quantify the extent of inappropriate prescription to elderly persons in the
primary care setting.
Methods: We systematically searched Ovid-Medline and Ovid-EMBASE from 1950 and 1980 respectively to March 2012. Two
independent reviewers screened and selected primary studies published in English that measured (in)appropriate
medication prescription among elderly persons (.65 years) in the primary care setting. We extracted data sources,
instruments for assessing medication prescription appropriateness, and the rate of inappropriate medication prescriptions.
We grouped the reported individual medications according to the Anatomical Therapeutic and Chemical (ATC) classification
and compared the median rate of inappropriate medication prescription and its range within each therapeutic class.
Results: We included 19 studies, 14 of which used the Beers criteria as the instrument for assessing appropriateness of
prescriptions. The median rate of inappropriate medication prescriptions (IMP) was 20.5% [IQR 18.1 to 25.6%.]. Medications
with largest median rate of inappropriate medication prescriptions were propoxyphene 4.52(0.10–23.30)%, doxazosin 3.96
(0.32 15.70)%, diphenhydramine 3.30(0.02–4.40)% and amitriptiline 3.20 (0.05–20.5)% in a decreasing order of IMP rate.
Available studies described unequal sets of medications and different measurement tools to estimate the overall prevalence
of inappropriate prescription.
Conclusions: Approximately one in five prescriptions to elderly persons in primary care is inappropropriate despite the
attention that has been directed to quality of prescription. Diphenhydramine and amitriptiline are the most common
inappropriately prescribed medications with high risk adverse events while propoxyphene and doxazoxin are the most
commonly prescribed medications with low risk adverse events. These medications are good candidates for being targeted
for improvement e.g. by computerized clinical decision support.
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Introduction
The elderly population is increasing, resulting in a concomitant
increase in chronic diseases and functional impairment [1].
Moreover many of the elderly persons suffer from co-morbid
conditions and disabilities that necessitate multiple medications or
polypharmacy [2,3].
Adverse drug events are common in ambulatory care settings
[4] and up to 35% of high risk older outpatients develop
preventable adverse drug events [5]. One cause of preventable
adverse drug events is the prescription of inappropriate medica-
tions. Inappropriate medication prescription (IMP) has been
defined as the prescription(s) that introduce(s) a significant risk of
an adverse drug related event when there is evidence for an
equally or more effective alternative medication [6]. It can also be
described as the failure to achieve the optimal quality of
medication use [7]. IMP has been classified as underprescribing,
misprescribing or overprescribing [8]. Several factors increase the
risk of IMP to elderly persons, including physiological changes like
reduction in renal and hepatic function, both of which are
detrimental of drug metabolism and disabilities like visual and
cognitive decline.
Aparasu et al. [9] and Gallagher et al. [10] reviewed, in 2000
and 2006 respectively, the incidence of IMP in elderly persons.
Both reviews included studies with elderly persons in any
healthcare setting from community dwelling elders to nursing
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home residents. Since then the criteria of assessing IMP have been
revised and new medication list based tools have been developed
[11–14]. In addition, there is lack of a detailed review that
compared the incidences of IMP within specific pharmacothera-
peutic classes. Such a review is necessary to allow for the
development of interventions that target the improvement of
prescription of specific medications.
The aim of this systematic review was to identify and summarize
published studies on IMP in elderly in primary care in order to
quantify its extent in elderly persons, and to identify medications
for which interventions may be implemented to improve
medication prescription quality.
Methods
Data Sources and Searches
We searched for relevant English articles using MeSH terms
and keywords in title and abstract in the Ovid EMBASE (1980–8th
March 2012), Ovid-Medline and Ovid Medline In-Process (1950
to 8th March 2012). The final literature search was performed on
8th March 2012. Figure 1 shows the search strategy and its
corresponding flow chart.
The search included terms related to elderly or geriatric
persons, medications, prescription, appropriate prescription, pri-
mary care, ambulatory care, general practice, office practice or
outpatient care as shown in Box S1. Duplicate articles found in
both two databases were removed. We screened the references of
the identified papers as supplementary search.
Study Selection
Two reviewers independently screened the titles and abstracts of
the retrieved articles. Inclusion was limited to studies that defined
the elderly as persons of 65 years and older who received
prescriptions in the primary care setting.
In this review, we only included papers that explicitly defined
the setting of prescription as outpatient clinics, office practice,
general practice and primary health care clinics. Studies that
included institutionalized patients and community dwelling elderly
without indicating the specific setting in which the prescriptions
were prescribed were excluded. In addition, studies which did not
report the clinical setting of the study were also excluded (see
checklist S1).
Our analysis was limited to studies that reported IMP using
drug-age criteria, which belong to the unconditionally inappropriate
medication prescription (IMP) for persons 65 years old or older.
Studies that reported IMP based on drug-disease criteria alone were
not included due to heterogeneity of reporting in literature. For
studies that evaluated IMP using the Beers criteria, we only
included data indicating the rate of IMP measured independent of
existing medical conditions and without any restrictions concern-
ing dosage or duration of use, to allow for comparability of IMP
with studies that did not use the Beers criteria. The principle of
unconditionally inappropropriate prescription holds true for most
of the list based criteria used for assessing IMP. Studies that
reported only a single medication were excluded as well as studies
that only described medication prescription for a specific disease
group of elderly persons such as dementia patients.
To be included, studies must have also reported the rate of IMP
for individual medications. This requirement allows for compara-
bility of IMP rates of individual medication across different studies.
Studies that reported rate of IMP after aggregating prescription by
pharmacological classes, for example cardiovascular drugs, were
excluded since it was impossible to find out which individual
medications were included.
Discrepancies between the two reviewers were resolved by
consensus involving a third reviewer.
Data Extraction
The two reviewers extracted data from the selected articles on
the following items: country; source of data used and instrument of
assessing the appropriateness of medication prescription. Addi-
tional data extracted included the number of patients involved in
each study and data on the rate of IMP. In the studies where more
than one instrument was used to measure the rate of IMP, the rate
estimated by the latest Beers criteria was used to compare studies.
When repeated measurements were reported, we used the most
recent rate of IMP. We calculated weighted rates of IMP for
individual medications in studies that reported rates of IMP in
males and females separately.
Discrepancies between these two reviewers were again resolved
by consensus involving the third reviewer.
Data Synthesis and Analysis
We calculated the median and ranges of the overall rates of IMP
for all medications reported in a study. We compared the overall
rates of IMP per country and source of data. For each study that
assessed IMP with more than one instrument, we compared the
incidences of IMP among them.
Subsequently, we grouped all individual medications reported
in the studies into their Anatomical Therapeutic and Chemical
(ATC) class. The ATC is a World Health Organisation (WHO)
hierarchical standard for classifying medications based on the
anatomical organ or system on which they act, the therapeutic
group and chemical composition of the active ingredient [15]. We
classified medications at the therapeutic (T) level of the ATC
classification. We considered the following eight major therapeutic
classes: analgesics and non-steroidal anti-inflammatory drugs
(NSAIDs), sedative hypnotics, anticholinergics and antihistamines,
antihypertensives, muscle relaxants, antidepressants, antiarrhyth-
mics and anticlotting medications. Medications which do not
belong to the above 8 therapeutic classes were not included for
practical purposes.
For each medication in a therapeutic class, we calculated the
median and range its IMP rate among all studies reporting on
it. Additionally, each medication was labelled as high risk (H) or
low risk (L) for adverse events to allow analysis at the level of a
medication’s adverse event risk profile. This risk categorization
was derived from the Beers criteria that distinguish between
IMP with potentially low and high severity of adverse outcomes
[6].
Results
Out of 946 articles screened 19 met the inclusion criteria for
detailed analysis. Table 1 lists the included articles. The studies
were conducted in 11 different countries. Seven studies were
performed in the United States of America and eight in Europe.
Two studies were conducted in Italy while one study was
conducted in each of the following EU countries: Germany, The
Netherlands, Ireland, Norway, Portugal, and the United King-
dom. Two studies were performed in Taiwan while one study was
conducted in Iran and India respectively.
Study Description
Eight different tools were used to assess the IMP rates. Beers
based criteria were used in 15 of 19 studies: one study used
Beers 1991, 2 studies used its 1997 version (Beers 1997), 11 used
its 2003 version, (Beers 2003) and one study used modifications
Inappropriate Medication Prescriptions to Elderly
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Figure 1. Article selection flow diagram.
doi:10.1371/journal.pone.0043617.g001
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of Beers 2003. Other instruments used for assessing medication
prescription included: Zhan’s criteria (1 studies) [16], More &
Romsdal Prescription Study (MRPS) list (1 study) [17]. One
study utilised the Health Plan Employer Data and Information
Set (HEDIS) criteria [18]. One study did not explicitly mention
the instrument used for assessing the quality of prescription [19].
Four studies used more than one instrument for assessing the
appropriateness of medication use. Two studies [20,21] that used
the Beers 1997 and 2003 versions found consistently lower IMP
percentages for the 1997 version: 27.7 vs. 38.5% and 18.5 vs.
20.0%. Pugh et al. found that Zhan’s criteria had had a low rate of
IMP (0.8%) when compared to unidentified reporting criteria
(33.3%) [19]. Ryan et al. compared Beers 2003 and the Screening
Tool for Older Persons Prescriptions (STOPP) and found IMP
rates of 18.3% and 21.4% respectively [22].
Six of the 18 studies (33.3%) used health insurance data, while 4
(22.2%) used prospectively collected data. Six studies (33.3%) used
national health surveys and databases, and one study (5.6%) used
general practice data. One study did not explicitly report the data
sources used.
Overall Inappropriate Medication Prescription Measures
The overall median rate of IMP among the elderly was 20.0%
with an absolute range of 2.9 to 38.5% and interquartile range of
16.8 to 25.4%. In the seven studies from the United States of
America, the median was 19.6% with a range from 4.5 to 33.3%.
In the European Union the median rate of inappropriate
prescription was 19.1% with a range of 2.9 to 38.5%.
Results for grouping prescriptions by the type of prescription
quality assessment instrument were: for Beers 1997 the median
IMP rate was 12.7% (range: 4.5 to 21.0%); for Beers 2003 the
median was 23.6% (range: 2.9 to 38.5%); and for Zhan’s criteria,
the only study reported a rate of IMP of 15.6%.
Inappropriate Prescription within Therapeutic Classes
IMP rates markedly varied across and within individual
therapeutic medication classes as shown in Table 2.
The four most commonly inappropriately prescribed medica-
tions were, in a decreasing order of IMP rate, were propoxyphene
4.52(0.10–23.30)%, doxazosin 3.96 (0.32–15.70)%, diphenhydra-
mine 3.30(0.02–4.40)% and amitriptiline 3.20 (0.05–20.5)%.
Non-steroidal Anti-inflammatory Drugs (NSAIDS)
Within the class of analgesic/NSAIDS, propoxyphene, which is
a low risk analgesic medication, had the highest IMP median of
4.52% with range of 0.10 to 23.30%, while meperidine and
pentozacine, which are high risk medications, had the lowest
median of 0.1% and 0.03% (with range of 0.01 to 0.10% and of
0.00 to 0.44%, respectively).
Antiarrhythmics
Dysopyramide had the lowest median rate of IMP 0.08(0.01–
0.4)% among the antiarrhythmic medications while the digoxin
was the most inappropropriately prescribed antiarrhythmic
medication 3.10(0.01–21.1)%. Disopyramide is classified as a high
risk medication while digoxin in a low risk medication.
Anticholinergics
Diphenhydramine was the most inappropriately prescribed
anticholinergic medication 3.30(0.02 4.40)% while belladonna
alkaloids were the least inappropriate prescribed anticholinergic
0.04(0.0–0.50)%. Both diphenhydramine and belladonna alkaloids
are high risk anticholinergic medications.
Anticlotting Medications
IMP was reported for two anticlotting medication as follows
dipyridamole 0.65(0.00–36.1)% and ticlopidine 0.86 (0.03–
Table 1. List of included articles.
No Author Year Country Data Source No. Patients Criteria Overall IMP rate
1 Goltz [27] 2012 Germany Insurance data 12513584 Beers 2003 2.90
2 Ghadimi [28] 2011 Iran Insurance data 2041 Beers 2003 30.0
3 Zaveri [29] 2010 India Prospective data 407 Beers 2003 23.6
4 Maio [30] 2010 Italy Others 91741 Modified Beers 2003 25.8
5 Ryan [22] 2009 Ireland Practice data 1329 Beers 2003 18.3
6 Lai [31] 2009 Taiwan Insurance data 2133864 Beers 2003 19.1
7 Lin [32] 2008 Taiwan Insurance data 5741 Beers 2003 23.7
8 Wilde [33] 2007 UK National health data 162000 Beers 2003 32.2
9 Bierman [34] 2007 USA National health data 965756 Zhan 15.6
10 Maio [35] 2006 USA Prospective data 100 Beers 2003 25.0
11 De Oliveira [20] 2006 Portugal Prospective data 213 Beers 2003 38.5
12 Maio [36] 2006 Italy Insurance data 849425 Beers 2003 18.0
13 Pugh [37] 2006 USA National health data 1096361 HEDIS HRME 19.6
14 Van der Hooft [21] 2005 Holland National health data 25258 Beers 2003 20.0
15 Pugh [19] 2005 USA National health data 1265434 Others 33.0
16 Curtis [38] 2004 USA Insurance data 765423 Beers 1997 21.0
17 Aparasu [39] 1999 USA National health data NA Beers 1997 4.45
18 Straand [17] 1999 Norway Prospective data 16874 MRPS List 13.5
19 Aparasu [40] 1997 USA National Health data NA Beers 1991 5.04
doi:10.1371/journal.pone.0043617.t001
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18.3)%. Dipyridamole is a low risk medication while toclopidine is
a high risk anticlotting agent.
Antidepressants
Doxepin was the least inappropriately 0.6(0.10–3.1) % pre-
scribed antidepressant medication while amitryptiline 3.2(0.05–
20.5)% was the most inappropriately prescribed. Both antidepres-
sants are high risk medications.
Antihypertensives
The median rate of IMP among the antihypertensive medica-
tion was lowest with guanethidine, 0.05 (0.00–0.1)%. Doxazosin
3.96 (0.32–15.7) % was reported to be the most inappropriately
prescribed antihypertensive medication. Guanethidine is a high
risk antihypertensive medication while doxazosin is a low risk
medication.
Muscle Relaxants
Among the muscle relaxants, metaxalone 0.05(0.00–0.1)% had
the lowest IMP rates while cyclobenzaprine 1.95 (1.20–9.7)% had
the highest. Both muscle relaxants are high risk medications.
Sedative Hypnotics
Diazepam 2.74 (0.05 30.05)% had the highest rates of IMP
while alprazolam 0.05 (0.00–0.10)% and oxazepam 0.05 (0.00–
0.10)% had the lowest rate of IMP among the sedative hypnotic
medications. All sedative hypnotics investigated are considered to
be high-risk medications.
Discussion
In spite of increasing attention to the quality of medication
prescription among elderly persons presenting to the primary care
setting, there are still high overall rates of inappropriate
medication prescription in primary care. This review found that
one in five (20.0%) prescriptions to elderly persons is inappro-
propriate with marked variation of rates of IMP within individual
therapeutic classes.
The overall prevalence of inappropriate prescription showed
wide variations between 2.9 and 38.5%. Several factors may
contribute to this variation. Different countries use different sets of
medications due to registration issues. There is hence no universal
list of medications and criteria for assessing the overall medication
use by older patients. Even within the United States inappropriate
medication use markedly differed, suggesting that there some
systematic differences between practices may exist. The differences
in the quality of prescribing across geographical regions have
recently been highlighted [23]. Cost and purchasing system of
medication is another probable reason for the medication choices
made in prescription [23]. Moreover, local drug procurement
policies and the structure of financing of medication are among
the probable factors that may contribute to the differences in
prescription patterns.
Consistent with our review, the review of Aparasu et al. in 2000
estimated that between 14.2% and 25% of elderly patients were
exposed to IMP [9]. Our review found an IMP rate of 20.0%. Of
note, 16 out 19 studies included in our review were published after
the year 2000 and the overall rate of IMP seems to not have
decreased considerably over the last 11 years despite the attention
that has been directed on the subject of IMP among elderly
patients. While Aparasu et al. included studies that were based only
on Beers criteria, our study included also non-Beers criteria based
studies which reported IMP based on individual medications.
Gallagher et al. found IMP rates of 12% among community
dwelling elderly and 40% among patients in nursing homes [10].
Patients who stay in nursing homes are likely to be exposed to
higher rates of IMP, as shown by Gallagher et al than those
patients who receive prescription in the primary care setting.
Unlike Gallagher et al. who reviewed studies that evaluated IMP in
all clinical settings, our review was limited to studies that included
patients who received their prescription in a primary care setting.
The overall rate of IMP (20.0%) that we report in this review falls
within the range (12–40%) reported by Gallagher et al. A more
recent review of IMP among the elderly, which was based on
studies that utilised administrative database, reported an IMP rate
ranging from 11.5–62.5%. This finding is consistent with our
overall IMP rate (20.0%) given that 12 out of 18 studies that we
included were performed using retrospective databases [24].
Unlike the three reviews described above, our study compared
the rate of IMP within therapeutic classes of medication. The
patterns of inappropriate prescriptions vary considerably within
therapeutic classes. Some medications with high risk for adverse
events such as diazepam and nifedipine have high prevalence of
inappropriate prescription compared to other medications in their
respective therapeutic classes. Prescription of high-risk medication
exposes the elderly to frequent and severe adverse drug events.
Alternative low risk medications should be prescribed when
available. There is therefore a need to move towards interventions
that can improve the quality of medication prescriptions among
the elderly in primary care such as employing clinical decision
support systems (CDSS). These systems can provide alerts during
prescription based on medication prescription guidelines such as
the Beers criteria. Good alert design which focuses on the relevant
information to the physician can improve the effectiveness of these
systems [25].
This review included various list based criteria for the
measurement of IMP which are comparable to each other given
that they report individual medications. Modifications that were
made in the various versions of the Beers criteria involved
inclusion and exclusion of individual medications on the list of
medications inappropriate for elderly patients. It was therefore
possible for us to compare the rates of IMP for individual
medications between studies even if they used different versions of
the Beers criteria. However, the overall rate of IMP was not
comparable between studies that used different versions of the
Beers criteria or other instruments to measure the rates of IMP.
We regard classification of medications as unconditionally
appropriate for elderly patients over 65 years as suggested by the
Beers criteria to be an over simplification of real clinical practice.
Some medications such digoxin or doxazocin may still be used
safely in patients who are older than 65 depending on their clinical
conditions. Improvements in the definition of inappropriate
medication prescription have been made based on drug-disease
combination in the elderly.
Twelve studies (12 of 19) relied on secondary analysis of existing
database sources such as National Health Service databases,
general practice and insurance databases, which were developed
for other purposes. Although previous studies have shown that
insurance databases do not necessarily have high quality clinical
notes documentation, they do generally have high quality of
medication documentation due to their use for reimbursement
purposes [26]. An outstanding drawback of insurance health
databases is, however, that only insured patients are enrolled.
There is patient selection bias in countries or regions where
insurance companies do not have universal coverage. Further-
more, we speculate that quality assurance and incentive programs
by some insurers may lead to better quality of care.
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Strengths and Weaknesses
A strength of our study is the analysis of medication prescription
appropriateness within therapeutic classes based on an interna-
tional standard. This classification mitigates the difficulty in
comparing inappropriate medication prescription measures orig-
inating from studies with different sets of medication that is
influenced by the availability of medications and local prescription
practices. This analysis is useful to policy makers and clinicians
when making choices between medications from the same
therapeutic class. We also compared IMP in studies which utilised
multiple instruments to measure quality of prescription.
We used extensive search criteria to capture the different ways
inappropriate prescription and elderly are referred to in the
published literature. Nevertheless our study maybe limited by
publication bias of studies on inappropriate medication prescrip-
tion. In addition, some of the excluded articles may be relevant but
due to uncertainty about or lack of reporting about the setting of
the prescription, they have been excluded.
Furthermore, our study was limited by the heterogeneity of the
included studies. The number of patients included in the studies
varied widely, which makes it difficult to estimate the overall
prevalence of IMP. Heterogeneity in reporting of the rates of IMP
limited our ability to completely compare rates of IMP for
individual medication in all studies. Some studies reported fewer
drugs than others. We believe that unavailability of some
medications in some countries may have resulted in the differences
in the sets of medications which were reported.
Although our study was limited to quantifying the extent of IMP
among elderly patients, it would be important to understand the
factors that predispose these patients to IMP. In addition,
understanding the relationship between IMP and the incidence
of adverse events to the patients will provide better guidance to the
prescribing physician. Demonstration of the relationship between
IMP and adverse events require the validation of the tools used to
define IMP in the first place.
Future studies that investigate therapeutic intents and choices of
medication among physicians may help further understanding of
their prescribing behaviour. This may particularly aid in
understanding how choices can be presented to physicians in
primary care. Such studies can result in improvement strategies by
computerized decision support.
Conclusion
Despite intensified efforts to scrutinize and improve the quality
of medication prescription among elderly persons in the primary
care setting, inappropriate medication prescriptions are still
common. Approximately one in five prescriptions to elderly
persons is inappropropriate. Diphenhydramine and amitriptiline
are the most common inappropriately prescribed medications with
high risk adverse events. These medications are good candidates
for being targeted for improvement e.g. by computerized clinical
decision support. Focused and systematic interventions are needed
to improve the quality of medication prescription in this patient
group.
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